Estrogen Inhibits Transforming Growth Factor β Signaling by Promoting Smad2/3 Degradation
Open Access
- 1 May 2010
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 285 (19), 14747-14755
- https://doi.org/10.1074/jbc.m109.093039
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Dual effects of TGF-β on ERα-mediated estrogenic transcriptional activity in breast cancerMolecular Cancer, 2009
- Activin and estrogen crosstalk regulates transcription in human breast cancer cellsEndocrine-Related Cancer, 2007
- Ki26894, a novel transforming growth factor‐β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell lineCancer Science, 2006
- Ligand-dependent switching of ubiquitin–proteasome pathways for estrogen receptorThe EMBO Journal, 2004
- Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target PromoterCell, 2003
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cellsProceedings of the National Academy of Sciences of the United States of America, 1997
- Partnership between DPC4 and SMAD proteins in TGF-β signalling pathwaysNature, 1996
- Receptor-associated Mad homologues synergize as effectors of the TGF-β responseNature, 1996
- Mechanism of activation of the TGF-β receptorNature, 1994